-
Unlocking the Potential of OBRSAs in the US: Insights on Challenges, Policy Changes, and Pathways Forward
Mar 10, 2025, 14:00 PM -
Going Beyond Excel vs. R: An Introduction To Visual Programming for Health Economics Modelling
Mar 10, 2025, 14:00 PM -
Incorporating Caregiver Burden in Japans Cost-Effectiveness Evaluation: A Case Study of Teduglutide for Pediatric Short Bowel Syndrome
Mar 10, 2025, 14:00 PM -
Colorectal Cancer Screening Initiation Modalities Among Newly Age-Eligible Medicaid-Insured Individuals in Texas
Mar 10, 2025, 14:00 PM -
Survival Analysis in Breast Cancer Patients Treated with Targeted Therapies and Conventional Therapies in the US: A Comparative Real World Study
Mar 10, 2025, 14:00 PM -
Treatment Patterns and Healthcare Resource Utilization of Patients Early in Schizophrenia Illness Initiating Aripiprazole Lauroxil Versus Oral Aripiprazole: A Retrospective Claims-Based Study
Mar 10, 2025, 14:00 PM -
Formulary Inclusion for Oncologic Indications: Comparing FDA-Approved Indications and Off-Label Compendia Support
Mar 10, 2025, 14:00 PM -
Examining Burden of Disease and Access to Care in Adults with X-Linked Hypophosphatemia in Brazil
Mar 10, 2025, 14:00 PM -
The Economic Burden of Narcolepsy in the United States: Matched Analysis of National Health and Wellness Survey Data
Mar 10, 2025, 14:00 PM -
Superior Performance of Generative AI After Application of Mixture-of-Agents LLMs in Outcomes Research
Mar 10, 2025, 14:00 PM -
Balancing Vulnerability and Freedom: Perspectives on HIV Cure-Related Trials With Analytical Treatment Interruption Among People With HIV and Healthcare Practitioners in the United States
Mar 10, 2025, 14:00 PM -
Cost-Benefit Evaluation of Containers in the Central Sterile Services Department (CSSD)
Mar 10, 2025, 14:00 PM -
Broadening the Scope of Value: Evaluating Payer Perspectives and Insights on ICER's Latest Initiatives and Tools
Mar 10, 2025, 14:00 PM -
Recurrent Patient-Reported Outcome (PRO)-Based Symptomatic Deterioration Predicts Survival and Disease Progression in Patients With Resectable Non-Small Cell Lung Cancer (NSCLC): Post-Hoc Analysis of RATIONALE-315
Mar 10, 2025, 14:00 PM -
A Descriptive Analysis of Demographic, Co-Morbid and Prescribing Data from the UK CPRD in People with Type 2 Diabetes and Cardiovascular Conditions
Mar 10, 2025, 14:00 PM -
Treatment Patterns, Clinical Outcomes, Healthcare Resource Utilization, and Healthcare Costs Among Patients With Metastatic Gastric/Gastroesophageal Junction Cancer in Medicare Beneficiaries
Mar 10, 2025, 14:00 PM -
Cost-Minimization: Consequences of Using the Lowest Cost Comparator Over the Weighted Average Cost (WAC)
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and Costs Among Adolescent Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): A US Administrative Claims Database Study
Mar 10, 2025, 14:00 PM -
Absenteeism and Presenteeism Associated With Chronic Conditions in a Canadian Working Population
Mar 10, 2025, 14:00 PM -
The Importance of Specifying the Estimand in Meta-Analyses in the Presence of Treatment Switching
Mar 10, 2025, 14:00 PM